Timeline

Nicolas Escriou
Permanent Researcher
02 Apr 2024
publication

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.

Read more
01 Apr 2023
publication

Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings

Read more
01 Jan 2022
publication

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.

Read more
21 May 2021
publication

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.

Read more
01 Jan 2021
publication

High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.

Read more
16 Dec 2020
publication

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.

Read more
02 Sep 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Read more
10 Apr 2020
project

CORONABODIES

Read more
04 Jul 2015
project

Bivalent vaccines derived from measles vaccine

Read more